{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:44:36Z","timestamp":1760820276530},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,24]],"date-time":"2010-10-24T00:00:00Z","timestamp":1287878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12072-010-9218-y","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T10:16:11Z","timestamp":1287828971000},"page":"597-602","source":"Crossref","is-referenced-by-count":5,"title":["Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still\u2019s disease"],"prefix":"10.1007","volume":"5","author":[{"given":"Sanjaya K.","family":"Satapathy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Isabel Fiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Del Rio Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costica","family":"Aloman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,24]]},"reference":[{"key":"9218_CR1","first-page":"1227","volume":"24","author":"D Lecointe","year":"2000","unstructured":"Lecointe D, Fabre M, Habes D, Mielot F, Bernard O, Nordmann P. Macrophage activation syndrome in primary human herpes virus-6 infection: a rare condition after liver transplantation in infants. Gastroenterol Clin Biol 2000;24:1227\u2013228","journal-title":"Gastroenterol Clin Biol"},{"key":"9218_CR2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/00007890-200112150-00024","volume":"72","author":"H Chisuwa","year":"2001","unstructured":"Chisuwa H, Hashikura Y, Nakazawa Y, Kamijo T, Nakazawa K, Nakayama J, et al. Fatal hemophagocytic syndrome after living-related liver transplantation: a report of two cases. Transplantation 2001;72:1843\u20131846","journal-title":"Transplantation"},{"key":"9218_CR3","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0041-1345(03)00511-6","volume":"35","author":"Z Karasu","year":"2003","unstructured":"Karasu Z, Kilic M, Cagirgan S, Lebe E, Yilmaz F, Demirbas T, et al. Hemophagocytic syndrome after living-related liver transplantation. Transplant Proc 2003;35:1482\u20131484","journal-title":"Transplant Proc"},{"key":"9218_CR4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pbc.20231","volume":"44","author":"TI George","year":"2005","unstructured":"George TI, Jeng M, Berquist W, Cherry AM, Link MP, Arber DA. Epstein\u2013Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature. Pediatr Blood Cancer 2005;44:270\u2013276","journal-title":"Pediatr Blood Cancer"},{"key":"9218_CR5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1440-1754.2006.00879.x","volume":"42","author":"W Hardikar","year":"2006","unstructured":"Hardikar W, Pang K, Al-Hebbi H, Curtis N, Couper R. Successful treatment of cytomegalovirus-associated haemophagocytic syndrome following paediatric orthotopic liver transplantation. J Paediatr Child Health 2006;42:389\u2013391","journal-title":"J Paediatr Child Health"},{"key":"9218_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9343(92)90048-G","volume":"93","author":"KF Wong","year":"1992","unstructured":"Wong KF, Chan JK. Reactive hemophagocytic syndrome\u2014a clinicopathologic study of 40 patients in an Oriental population. Am J Med 1992;93:177\u2013180","journal-title":"Am J Med"},{"key":"9218_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005792-198811000-00002","volume":"67","author":"AP Reiner","year":"1988","unstructured":"Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine 1988;67:369\u2013388","journal-title":"Medicine"},{"key":"9218_CR8","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","volume":"349","author":"CL Leonardi","year":"2003","unstructured":"Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, et al. Etanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003;349:2014\u20132022","journal-title":"N Engl J Med"},{"key":"9218_CR9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","volume":"26","author":"GJ Tobon","year":"2007","unstructured":"Tobon GJ, Ca\u00f1as C, Jaller JJ, Restrepo JC, Anaya JM. Serious liver disease induced by infliximab. Clin Rheumatol 2007;26:578\u2013581","journal-title":"Clin Rheumatol"},{"key":"9218_CR10","unstructured":"Everitt DE. Centocor. Important drug warning. December 2004. http:\/\/www.fda.gov\/downloads\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/UCM166923.pdf (accessed August 2009)"},{"key":"9218_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2230.2008.03088.x","volume":"34","author":"DA Fairhurst","year":"2009","unstructured":"Fairhurst DA, Sheehan-Dare R. Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis. Clin Exp Dermatol 2009;34:421\u2013422","journal-title":"Clin Exp Dermatol"},{"key":"9218_CR12","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1529-0131(200108)44:8<1966::AID-ART339>3.0.CO;2-3","volume":"44","author":"G Saleem","year":"2001","unstructured":"Saleem G, Li SC, MacPherson BR, Cooper SM. Hepatitis with interface inflammation and IgG, IgM and IgA anti double stranded DNA antibodies following infliximab therapy. Arthritis Rheum 2001;44:1966\u20131968","journal-title":"Arthritis Rheum"},{"key":"9218_CR13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","volume":"64","author":"V Germano","year":"2005","unstructured":"Germano V, Picchianti Diamanti A, Baccano G, Natale E, Onetti Muda A, Priori R, et al. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 2005;64:1519\u20131520","journal-title":"Ann Rheum Dis"},{"key":"9218_CR14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","volume":"187","author":"G Ozorio","year":"2007","unstructured":"Ozorio G, McGarity B, Bak H, Jordan AS, Lau H, Marshall C. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis. Med J Aust 2007;187:524\u2013526","journal-title":"Med J Aust"},{"key":"9218_CR15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/lt.21793","volume":"15","author":"G Piton","year":"2009","unstructured":"Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, et al. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report. Liver Transpl 2009;15:682\u2013685","journal-title":"Liver Transpl"},{"key":"9218_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0b013e3280116ccc","volume":"19","author":"S Lal","year":"2007","unstructured":"Lal S, Steinhart AH. Infliximab for ulcerative colitis following liver transplantation. Eur J Gastroenterol Hepatol 2007;19:277\u2013280","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9218_CR17","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","volume":"43","author":"PJ Charles","year":"2000","unstructured":"Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000;43:2383\u20132390","journal-title":"Arthritis Rheum"},{"key":"9218_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","volume":"64","author":"C Eriksson","year":"2005","unstructured":"Eriksson C, Engstrand S, Sundqvist KG, Rantapaa-Dahlqvist S. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF-alpha. Ann Rheum Dis 2005;64:403\u2013407","journal-title":"Ann Rheum Dis"},{"key":"9218_CR19","first-page":"29","volume":"18","author":"JI Henter","year":"1991","unstructured":"Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29\u201333","journal-title":"Semin Oncol"},{"key":"9218_CR20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3201\/eid0606.000608","volume":"6","author":"DN Fisman","year":"2000","unstructured":"Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000;6:601\u2013608","journal-title":"Emerg Infect Dis"},{"key":"9218_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0925-5710(97)00584-7","volume":"66","author":"S Imashuku","year":"1997","unstructured":"Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997;66:135\u2013151","journal-title":"Int J Hematol"},{"key":"9218_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/s10165-004-0293-6","volume":"14","author":"S Kumakura","year":"2004","unstructured":"Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 2004;14:205\u2013215","journal-title":"Mod Rheumatol"},{"key":"9218_CR23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI116721","volume":"92","author":"H Kawaguchi","year":"1993","unstructured":"Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, et al. Epstein\u2013Barr virus-infected T lymphocytes in Epstein\u2013Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993;92:1444\u20131450","journal-title":"J Clin Invest"},{"key":"9218_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S0036-46652008000200012","volume":"50","author":"FF Tuon","year":"2008","unstructured":"Tuon FF, Gomes VS, Amato VS, Graf ME, Fonseca GH, Lazari C, et al. Hemophagocytic syndrome associated with hepatitis A: case report and literature review. Rev Inst Med Trop Sao Paulo 2008;50:123\u2013127","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"9218_CR25","first-page":"359","volume":"55","author":"T Yoshizumi","year":"2008","unstructured":"Yoshizumi T, Taketomi A, Kayashima H, Harada N, Uchiyama H, Yamashita Y, et al. Successful treatment for a patient with hemophagocytic syndrome after a small-for-size graft liver transplantation. Hepatogastroenterology 2008;55:359\u2013562","journal-title":"Hepatogastroenterology"},{"key":"9218_CR26","first-page":"923","volume":"52","author":"N Taniai","year":"2005","unstructured":"Taniai N, Akimaru K, Kawano Y, Mizuguchi Y, Shimizu T, Takahashi T, et al. Hemophagocytic syndrome after living-donor liver transplantation for fulminant liver failure: a case report. Hepatogastroenterology 2005;52:923\u2013926","journal-title":"Hepatogastroenterology"},{"key":"9218_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2141.1994.tb04905.x","volume":"87","author":"K Akashi","year":"1994","unstructured":"Akashi K, Hayashi S, Gondo H, Mizuno S, Harada M, Tamura K, et al. Involvement of interferon-gamma and macrophage colony stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 1994;87:243\u2013250","journal-title":"Br J Haematol"},{"key":"9218_CR28","first-page":"1","volume":"72","author":"S Imashuku","year":"2000","unstructured":"Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol 2000;72:1\u201311","journal-title":"Int J Hematol"},{"key":"9218_CR29","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood.V86.12.4706.bloodjournal86124706","volume":"86","author":"S Imashuku","year":"1995","unstructured":"Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H, Chen J, et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood 1995;86:4706\u20134707","journal-title":"Blood"},{"key":"9218_CR30","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood 2005;105:1648\u20131651","journal-title":"Blood"},{"key":"9218_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJM198702053160617","volume":"316","author":"N Esumi","year":"1987","unstructured":"Esumi N, Ikushima S, Todo S, Imashuku S. Hyperferritinemia in malignant histiocytosis and virus-associated hemophagocytic syndrome. N Engl J Med 1987;316:346\u2013347","journal-title":"N Engl J Med"},{"key":"9218_CR32","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/1097-0142(19950401)75:7<1700::AID-CNCR2820750722>3.0.CO;2-D","volume":"75","author":"S Hibi","year":"1995","unstructured":"Hibi S, Ikushima S, Fujiwara F, Hashida T, Tsunamoto K, Todo S, et al. Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 1995;75:1700\u20131705","journal-title":"Cancer"},{"key":"9218_CR33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0002-9270(00)02425-4","volume":"96","author":"C Kerguenec de","year":"2001","unstructured":"de Kerguenec C, Hillaire S, Molini\u00e9 V, Gardin C, Degott C, Erlinger S, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 2001;96:852\u2013857","journal-title":"Am J Gastroenterol"},{"key":"9218_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajh.2830350409","volume":"35","author":"E Azuma","year":"1990","unstructured":"Azuma E, Tabata N, Shibata T, Komada Y, Ito M, Atsumi S, et al. G-CSF enhanced granulocyte production in a child with severe neutropenia in the setting of fatal virus-associated hemophagocytic syndrome. Am J Hematol 1990;35:266\u2013268","journal-title":"Am J Hematol"},{"key":"9218_CR35","doi-asserted-by":"crossref","unstructured":"Kalliolias GD, Liossis SN. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still\u2019s disease and systemic-onset juvenile idiopathic arthritis. Expert Opin Investig Drugs 2008;17:349\u2013359","DOI":"10.1517\/13543784.17.3.349"},{"key":"9218_CR36","doi-asserted-by":"crossref","unstructured":"Naumann L, Feist E, Natusch A, Langen S, Krause A, Buttgereit F, et al. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still\u2019s disease. Ann Rheum Dis 2010;69:466\u2013467","DOI":"10.1136\/ard.2009.108068"},{"key":"9218_CR37","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"JB Arlet","year":"2006","unstructured":"Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature. Ann Rheum Dis 2006;65:1596\u20131601","journal-title":"Ann Rheum Dis"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-010-9218-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-010-9218-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-010-9218-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T07:21:49Z","timestamp":1592032909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-010-9218-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9218"],"URL":"https:\/\/doi.org\/10.1007\/s12072-010-9218-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,24]]}}}